NovoBiotic
Dr. Spoering is responsible for the development and evaluation of new methodologies and technologies at NovoBiotic Pharmaceuticals. She also supervises the fermentation facility including the production of teixobactin for research purposes. Her doctoral research investigated the molecular mechanisms of bacterial tolerance to antibiotics.
This person is not in any offices
NovoBiotic
NovoBiotic Pharmaceuticals is a privately held, early stage biotechnology company focused on the discovery and development.